Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke

Stroke

Volumn 45, Issue 8, 2014, Pages 2292-2297

  Navi, Babak B ^a,b,c   Singer, Samuel ^c   Merkler, Alexander E ^a   Cheng, Natalie T ^a   Stone, Jacqueline B ^c   Kamel, Hooman ^a,b   Iadecola, Costantino ^a,b   Elkind, Mitchell S V ^d,e   Deangelis, Lisa M ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Department of Neurology College of Physicians and Surgeons ^*  (United States)

^e Department of Medicine   (United States)

Author keywords

endocarditis, non infective; mortality; survival

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; AUTOPSY; BLOOD CULTURE; BRAIN ISCHEMIA; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; FUNCTIONAL STATUS; HAZARD RATIO; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL TIME; TERTIARY CARE CENTER;

ENDOCARDITIS, NON-INFECTIVE; MORTALITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE;

EID: 84906101733     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005784     Document Type: Article

References (24)

1. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4:465-473.
2. Dammacco F, Vacca A, Procaccio P, Ria R, Marech I, Racanelli V. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med. 2013;13:85-97.
3. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore). 1977;56:1-37.
4. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025-2030.
5. Kim SG, Hong JM, Kim HY, Lee J, Chung PW, Park KY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41:798-801.
6. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985;64:16-35.
7. Schwarzbach CJ, Schaefer A, Ebert A, Held V, Bolognese M, Kablau M, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43:3029-3034.
8. Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med. 1987;83:746-756.
9. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007;12:518-523.
10. Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol. 2006;97:894-898.
11. Bal S, Menon B, Demchuk A. Relationship of endocarditis, disseminated intravascular coagulation, and embolic signals in cancer with stroke. Ann Neurol. 2012;71:146.
12. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Lowmolecular- weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
13. Navi BB, Singer S, Merkler AE, Cheng NT, Stone JB, Kamel H, et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer [published online ahead of print May 21, 2014]. Neurology. http://www.neurology.org/content/early/2014/05/21/WNL. 0000000000000539.short?rss=1. Accessed June 12, 2014.
14. Navi BB, Reichman JS, Berlin D, Reiner AS, Panageas KS, Segal AZ, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010;74:494-501.
15. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
16. Lowenstein SR. Medical record reviews in emergency medicine: the blessing and the curse. Ann Emerg Med. 2005;45:452-455.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
19. Feldman DR, Patil S, Trinos MJ, Carousso M, Ginsberg MS, Sheinfeld J, et al. Progression-free and overall survival in patients with relapsed/ refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design. Cancer. 2012;118:981-986.
20. Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol. 2010;30:311-319.
21. Redfors P, Jood K, Holmegaard L, Rosengren A, Blomstrand C, Jern C. Stroke subtype predicts outcome in young and middle-aged stroke sufferers. Acta Neurol Scand. 2012;126:329-335.
22. Vallejos J, Jaramillo A, Reyes A, Illanes S, Orellana P, Manterola J, et al. Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile. J Stroke Cerebrovasc Dis. 2012;21:621-628.
23. Seok JM, Kim SG, Kim JW, Chung CS, Kim GM, Lee KH, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol. 2010;68:213-219.
24. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34:122-126.